Association of functional polymorphism of ApoB promoter with hepatitis C virus infection

Clinica Chimica Acta

Volumn 401, Issue 1-2, 2009, Pages 124-127

  Zhu, Chengliang ^a   Zhang, Rui ^a   Liu, Dandan ^a   Mukhtar, Muhammad Mahmood ^a   Liu, Weiyong ^a   Peng, Guiqing ^a   Wang, Ke ^a   Hao, Qian ^a   Xu, Yilin ^a   Liu, Fang ^a   Zhu, Ying ^a   Wu, Jianguo ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Apolipoprotein B; Hepatitis C virus; Polymorphism; Viral hepatitis; Viral infection and clearance

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

HEPATITIS C VIRUS;

EID: 58549115041     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.12.001     Document Type: Article

References (28)

1. Aalto-Setala K., Gylling H., Helve E., et al. Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet 82 (1989) 305-307
2. Cuthbert J.A. Hepatitis C: progress and problems. Clin Microbiol Rev 7 (1994) 505-532
3. Marcellin P. Hepatitis C: the clinical spectrum of the disease. J Hepatol 31 Suppl 1 (1999) 9-16
4. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96 (1999) 12766-12771
5. Cormier E.G., Tsamis F., Kajumo F., Durso R.J., Gardner J.P., and Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 101 (2004) 7270-7274
6. Germi R., Crance J.M., Garin D., et al. Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol 68 (2002) 206-215
7. Lozach P.Y., Lortat-Jacob H., de Lacroix de Lavalette A., et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278 (2003) 20358-20366
8. Monazahian M., Bohme I., Bonk S., et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57 (1999) 223-229
9. Pileri P., Uematsu Y., Campagnoli S., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
10. Scarselli E., Ansuini H., Cerino R., et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21 (2002) 5017-5025
11. Thomssen R., Bonk S., Propfe C., Heermann K.H., Kochel H.G., and Uy A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 181 (1992) 293-300
12. Wunschmann S., Medh J.D., Klinzmann D., Schmidt W.N., and Stapleton J.T. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 74 (2000) 10055-10062
13. Andre P., Komurian-Pradel F., Deforges S., et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76 (2002) 6919-6928
14. Prince A.M., Huima-Byron T., Parker T.S., and Levine D.M. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepat 3 (1996) 11-17
15. Yang C.Y., Kim T.W., Pao Q., et al. Structure and conformational analysis of lipid-associating peptides of apolipoprotein B-100 produced by trypsinolysis. J Protein Chem 8 (1989) 689-699
16. van 't Hooft F.M., Jormsjo S., Lundahl B., Tornvall P., Eriksson P., and Hamsten A. A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein. J Lipid Res 40 (1999) 1686-1694
17. Sposito A.C., Gonbert S., Turpin G., Chapman M.J., and Thillet J. Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levels. Arterioscler Thromb Vasc Biol 24 (2004) 2192-2195
18. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
19. Andre P., Perlemuter G., Budkowska A., Brechot C., and Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 25 (2005) 93-104
20. Li H., Liu Z., Han Q., Li Y., and Chen J. Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese. J Med Virol 78 (2006) 1289-1295
21. Price D.A., Bassendine M.F., Norris S.M., et al. Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut 55 (2006) 715-718
22. Wozniak M.A., Itzhaki R.F., Faragher E.B., James M.W., Ryder S.D., and Irving W.L. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 36 (2002) 456-463
23. Choumerianou D.M., Maumus S., Skoumas J., et al. Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia. Clin Chem Lab Med 44 (2006) 799-806
24. Rios D.L., Vargas A.F., Torres M.R., Zago A.J., Callegari-Jacques S.M., and Hutz M.H. Interaction between SREBP-1a and APOB polymorphisms influences total and low-density lipoprotein cholesterol levels in patients with coronary artery disease. Clin Genet 63 (2003) 380-385
25. Turner P.R., Talmud P.J., Visvikis S., Ehnholm C., and Tiret L. DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis 116 (1995) 221-234
26. Siagris D., Christofidou M., Theocharis G.J., et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 13 (2006) 56-61
27. Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8 (1988) 1-21
28. Petit J.M., Benichou M., Duvillard L., et al. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol 98 (2003) 1150-1154